Characteristics and outcomes of a cohort of COVID-19 patients in the Province of Reggio Emilia, Italy

This article has been Reviewed by the following groups

Read the full article See related articles

Abstract

No abstract available

Article activity feed

  1. SciScore for 10.1101/2020.04.13.20063545: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    Institutional Review Board StatementIRB: Ethics approval: The study has been approved by the Area Vasta Emilia Nord Ethic Committee on 07/04/2020 n° 2020/0045199.
    Consent: Patient consent: In accordance with the Italian privacy law, no patient or parental consent is required for large retrospective population-based studies approved by the competent Ethics Committee if data are published only in aggregated form.
    Randomizationnot detected.
    Blindingnot detected.
    Power Analysisnot detected.
    Sex as a biological variablenot detected.

    Table 2: Resources

    No key resources detected.


    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).


    Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:
    Strengths and weaknesses of the study: The main limitation of this study is that we do not have any information on treatments administered in hospital or prescribed at home. Further analyses, requiring ad hoc data collection, must be conducted to study how therapies interacted with the natural history of the disease and with prognostic factors. Another limitation of this study is that it is based only on routinely collected data for hospitalizations to define comorbidities. The limitations of such an approach have been highlighted in the literature and collecting a long history of hospitalization has been suggested as an effective measure to reduce misclassification and minimize underestimation of the prevalence. Furthermore, this is the only way to obtain reliable information on a population-based cohort including non-hospitalized patients. Comparison with other studies and interpretation: While in this study we focused on the risk of hospitalization and death in a cohort of SARS-CoV-2 patients diagnosed during the epidemic in Northern Italy, it also provided us with the opportunity to describe the pattern of distribution of the disease in the whole population. We observed different age-specific risks for females and males resulting in an overall equal proportion of cases. This observation is consistent with previous studies including all symptomatic cases [8,13,14] except for a report on the early phases of the epidemic in Lombardy.[6] Indeed, females had a higher risk amon...

    Results from TrialIdentifier: No clinical trial numbers were referenced.


    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.


    Results from JetFighter: We did not find any issues relating to colormaps.


    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.